These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target. Xue ST, Li K, Gao Y, Zhao LY, Gao Y, Yi H, Jiang JD, Li ZR. Autophagy; 2020 Oct; 16(10):1823-1837. PubMed ID: 31986961 [Abstract] [Full Text] [Related]
5. Histone deacetylase inhibitors promote epithelial-mesenchymal transition in Hepatocellular Carcinoma via AMPK-FOXO1-ULK1 signaling axis-mediated autophagy. Xiao Q, Liu H, Wang HS, Cao MT, Meng XJ, Xiang YL, Zhang YQ, Shu F, Zhang QG, Shan H, Jiang GM. Theranostics; 2020 Oct; 10(22):10245-10261. PubMed ID: 32929346 [Abstract] [Full Text] [Related]
6. Regulation of SIRT1/AMPK axis is critically involved in gallotannin-induced senescence and impaired autophagy leading to cell death in hepatocellular carcinoma cells. Kwon HY, Kim JH, Kim B, Srivastava SK, Kim SH. Arch Toxicol; 2018 Jan; 92(1):241-257. PubMed ID: 28676953 [Abstract] [Full Text] [Related]
10. Aescin-induced reactive oxygen species play a pro-survival role in human cancer cells via ATM/AMPK/ULK1-mediated autophagy. Li B, Wu GL, Dai W, Wang G, Su HY, Shen XP, Zhan R, Xie JM, Wang Z, Qin ZH, Gao QG, Shen GH. Acta Pharmacol Sin; 2018 Dec 15; 39(12):1874-1884. PubMed ID: 29921885 [Abstract] [Full Text] [Related]
13. Substituted indole derivatives as UNC-51-like kinase 1 inhibitors: Design, synthesis and anti-hepatocellular carcinoma activity. Zhao LY, Li SY, Zhou ZY, Han XY, Li K, Xue ST, Jiang JD. Biomed Pharmacother; 2024 Sep 15; 178():117260. PubMed ID: 39116788 [Abstract] [Full Text] [Related]
14. SLC45A4 promotes glycolysis and prevents AMPK/ULK1-induced autophagy in TP53 mutant pancreatic ductal adenocarcinoma. Chen W, Huang F, Huang J, Li Y, Peng J, Zhuang Y, Huang X, Lu L, Zhu Z, Zhang S. J Gene Med; 2021 Sep 15; 23(9):e3364. PubMed ID: 34010493 [Abstract] [Full Text] [Related]
15. PSPH induces cell autophagy and promotes cell proliferation and invasion in the hepatocellular carcinoma cell line Huh7 via the AMPK/mTOR/ULK1 signaling pathway. Zhang J, Wang E, Zhang L, Zhou B. Cell Biol Int; 2021 Feb 15; 45(2):305-319. PubMed ID: 33079432 [Abstract] [Full Text] [Related]
17. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis. Lin C, Xiang Y, Sheng J, Liu S, Cui M, Zhang X. J Physiol Biochem; 2020 Aug 15; 76(3):469-481. PubMed ID: 32621257 [Abstract] [Full Text] [Related]
18. Lipid-modified cell-penetrating peptide-based self-assembly micelles for co-delivery of narciclasine and siULK1 in hepatocellular carcinoma therapy. Wang X, Wu F, Li G, Zhang N, Song X, Zheng Y, Gong C, Han B, He G. Acta Biomater; 2018 Jul 01; 74():414-429. PubMed ID: 29787814 [Abstract] [Full Text] [Related]
19. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells. Wang ST, Ho HJ, Lin JT, Shieh JJ, Wu CY. Cell Death Dis; 2017 Feb 23; 8(2):e2626. PubMed ID: 28230855 [Abstract] [Full Text] [Related]
20. Autophagic protein ULK1 regulates FOXM1 signalling in human hepatoma cells. Rajak S, Raza S, Tewari A, Yadav S, Ghosh S, Yen PM, Sinha RA. Biochem Biophys Res Commun; 2020 Nov 19; 532(4):570-575. PubMed ID: 32900486 [Abstract] [Full Text] [Related] Page: [Next] [New Search]